Colorcon to buy BASF's Kollicoat coating system product

By Gareth Macdonald contact

- Last updated on GMT

Colorcon to buy BASF's Kollicoat coating system product

Related tags: Marketing, Active ingredient

Colorcon will buy BASF’s Kollicoat excipient coating system product line in a deal announced today.

The transaction – which is subject to approval by Brazilian competition authorities – will include BASF’s Kollicoat coating system product business, including its “current customer business, inventory and relevant know-how” according to Colorcon.

A Colorcon spokeswoman told us the firm will not be taking on any BASF staff or facilities involved in the manufacture of the Kollicoat coating product.

In addition to the coating system, BASF’s Kollicoat range comprises polymer excipients. The German chemical firm launched the newest Kollicoat product in the range last month​ at industry​ event in Glasgow, Scotland.

BASF spokesman Andres Christian Orthofer told us firm is only selling the coating systems part of its business to Colorcon, adding that “our Kollicoat product line has been and will remain a core part of our excipients business​.”

News of the coating system product sale comes a year after BASF sold the majority of its active pharmaceutical ingredients (API) business to Swiss fine chemicals firm Siegfried holding.

At the time​ BASF told us the divestiture will allow it to “focus its pharmaceutical business on its core expertise and unique strength in excipients and selected active pharmaceutical ingredients (APIs)."

The coating proaduct Colorcon will buy is not part of the industrial coatings business that BASF intends to sell to AkzoNobel for €475m ($529m).

Related news

Show more

Related products

show more

Innovations in OSD

Innovations in OSD

Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Related suppliers

Follow us

Products

View more

Webinars